Profile data is unavailable for this security.
About the company
RUA Life Sciences plc is a United Kingdom-based holding company of a group of medical device businesses focused on the exploitation of long-term implantable biostable polymer (Elast-Eon). Elast-Eon's biostability is comparable to silicone while exhibiting excellent mechanical, blood contacting and flex-fatigue properties. The Company has four business units: RUA Contract Manufacture, RUA Biomaterials, RUA Vascular and RUA Structural Heart. RUA Contract Manufacture is an end-to-end contract developer and manufacturer of medical devices and implantable fabric specialist. It provides sub-contract manufacturing, assembly, packing and services to the medical device sector from its Class 7 and 8 cleanroom suites. RUA Biomaterials is a licensor of Elast-Eon polymers to the medical device industry. RUA Vascular is engaged in the commercialization of open surgical vascular grafts and patches. RUA Structural Heart is engaged in the development of polymeric leaflet systems for heart valves.
- Revenue in GBP (TTM)2.19m
- Net income in GBP-1.44m
- Incorporated1996
- Employees33.00
- LocationRua Life Sciences PLC2 Drummond Crescent, IrvineAYRSHIRE KA11 5ANUnited KingdomGBR
- Phone+44 129 431 7073
- Fax+44 193 225 1113
- Websitehttps://rualifesciences.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Deltex Medical Group plc | 1.78m | -1.29m | 2.23m | 37.00 | -- | 0.6840 | -- | 1.25 | -0.0007 | -0.0007 | 0.001 | 0.0015 | 0.3156 | 0.9113 | 5.23 | 48,135.14 | -22.92 | -14.66 | -35.89 | -21.81 | 62.21 | 71.84 | -72.60 | -32.93 | 0.4855 | -3.31 | 0.4245 | -- | -28.44 | -18.55 | -11.97 | -- | 9.78 | -- |
Image Scan Holdings Plc | 2.56m | -11.06k | 2.81m | 14.00 | -- | 2.75 | 30.50 | 1.10 | -0.00008 | -0.00008 | 0.0187 | 0.0102 | 1.07 | 2.38 | 5.38 | 183,209.30 | -0.4626 | -1.15 | -0.7257 | -1.77 | 50.57 | 51.36 | -0.4312 | -1.01 | 1.69 | -- | 0.00 | -- | 47.98 | -3.08 | 145.65 | -- | 40.19 | -- |
Aptamer Group PLC | 1.04m | -7.01m | 4.51m | 54.00 | -- | 0.5519 | -- | 4.36 | -0.0804 | -0.0804 | 0.0048 | 0.0043 | 0.1648 | 3.89 | 2.68 | 19,166.67 | -111.66 | -- | -154.29 | -- | -11.88 | -- | -677.39 | -- | 2.04 | -39.28 | 0.3467 | -- | -56.59 | -- | -274.39 | -- | -- | -- |
Myhealthchecked PLC | 10.98m | -159.00k | 5.72m | 10.00 | -- | 0.8066 | 89.42 | 0.5214 | -0.0031 | -0.0031 | 0.2111 | 0.1674 | 0.8863 | 10.98 | 4.44 | 1,097,700.00 | -1.28 | -7.24 | -1.81 | -10.39 | 18.66 | 22.82 | -1.45 | -5.13 | 2.46 | -- | 0.003 | -- | -50.81 | 368.95 | -110.48 | -- | -2.00 | -- |
Surgical Innovations Group Plc | 12.01m | -509.00k | 5.93m | 101.00 | -- | 0.5783 | 23.91 | 0.4937 | -0.0005 | -0.0005 | 0.0129 | 0.0112 | 0.8032 | 2.85 | 5.89 | 118,950.50 | -3.40 | -8.19 | -4.18 | -9.94 | 28.70 | 32.51 | -4.24 | -13.31 | 1.23 | -4.45 | 0.1368 | -- | 5.94 | 1.84 | -292.80 | -- | 7.20 | -- |
Feedback plc | 886.00k | -3.49m | 6.20m | 24.00 | -- | 0.6096 | -- | 6.99 | -0.2614 | -0.2614 | 0.0664 | 0.6726 | 0.0774 | -- | 3.74 | 36,916.67 | -30.44 | -28.58 | -32.67 | -31.74 | 90.60 | 92.61 | -393.47 | -299.13 | -- | -- | 0.00 | -- | 74.15 | 17.46 | -37.74 | -- | 56.22 | -- |
Rua Life Sciences PLC | 2.19m | -1.44m | 6.98m | 33.00 | -- | 1.04 | -- | 3.19 | -0.0551 | -0.0551 | 0.0653 | 0.1157 | 0.3168 | 4.30 | 3.91 | 66,393.94 | -20.82 | -24.63 | -22.39 | -26.81 | 81.06 | -- | -65.72 | -97.07 | 8.81 | -23.34 | 0.0514 | -- | 0.5507 | 36.46 | 28.11 | -- | 122.88 | -- |
Cambridge Nutritional Sciences PLC | 9.77m | -328.00k | 8.03m | 94.00 | -- | 0.9093 | 24.94 | 0.8216 | -0.0015 | -0.0015 | 0.0411 | 0.0407 | 0.6908 | 5.39 | 4.62 | 103,978.70 | -2.32 | -11.43 | -2.60 | -12.98 | 61.86 | 58.79 | -3.36 | -26.72 | 5.03 | -- | 0.0151 | -- | 29.53 | 2.22 | 89.66 | -- | -53.43 | -- |
Proteome Sciences plc | 4.04m | -4.08m | 8.69m | 35.00 | -- | -- | -- | 2.15 | -0.0138 | -0.0138 | 0.0137 | -0.0178 | 0.3927 | 4.69 | 4.61 | 115,285.70 | -39.69 | -1.22 | -- | -- | 2.11 | 54.53 | -101.07 | -2.20 | 0.1388 | -3.70 | 1.63 | -- | -35.37 | 10.52 | -284.38 | -- | 126.22 | -- |
Genedrive PLC | 272.00k | -5.00m | 11.02m | 43.00 | -- | 1.93 | -- | 40.53 | -0.0407 | -0.0407 | 0.0022 | 0.0098 | 0.0658 | -- | 1.60 | 6,325.58 | -120.84 | -97.55 | -197.86 | -128.51 | -- | -- | -1,837.50 | -797.03 | 1.36 | -7.49 | 0.0789 | -- | 12.24 | -50.95 | -10.16 | -- | 16.72 | -- |
Genincode PLC | 2.16m | -7.02m | 11.68m | 36.00 | -- | 4.09 | -- | 5.41 | -0.0732 | -0.0732 | 0.0225 | 0.0135 | 0.2703 | 21.88 | 3.33 | 60,000.00 | -87.79 | -- | -124.10 | -- | 47.31 | -- | -324.81 | -- | 1.24 | -- | 0.1883 | -- | 51.05 | -- | -26.21 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Dowgate Capital Ltd.as of 18 Dec 2023 | 6.03m | 9.72% |
Rathbones Investment Management Ltd.as of 19 Dec 2023 | 4.13m | 6.66% |
Unicorn Asset Management Ltd.as of 31 Jul 2024 | 33.61k | 0.05% |